SI1321139T1 - 2-indanilamino-derivati za zdravljenje kronicne, akutne ali vnetne bolecine - Google Patents
2-indanilamino-derivati za zdravljenje kronicne, akutne ali vnetne bolecineInfo
- Publication number
- SI1321139T1 SI1321139T1 SI200130651T SI200130651T SI1321139T1 SI 1321139 T1 SI1321139 T1 SI 1321139T1 SI 200130651 T SI200130651 T SI 200130651T SI 200130651 T SI200130651 T SI 200130651T SI 1321139 T1 SI1321139 T1 SI 1321139T1
- Authority
- SI
- Slovenia
- Prior art keywords
- indanylamino
- chronic
- deratives
- acute
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01130638A EP1321139B1 (en) | 2001-12-21 | 2001-12-21 | 2-Indanylamino deratives for the therapy of chronic, acute or inflammatory pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1321139T1 true SI1321139T1 (sl) | 2007-02-28 |
Family
ID=8179649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200130651T SI1321139T1 (sl) | 2001-12-21 | 2001-12-21 | 2-indanilamino-derivati za zdravljenje kronicne, akutne ali vnetne bolecine |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20050222266A1 (sl) |
| EP (2) | EP1321139B1 (sl) |
| JP (1) | JP4427329B2 (sl) |
| AT (1) | ATE336990T1 (sl) |
| BR (1) | BR0207371A (sl) |
| CA (1) | CA2470990C (sl) |
| DE (1) | DE60122541T2 (sl) |
| DK (1) | DK1321139T3 (sl) |
| ES (1) | ES2270947T3 (sl) |
| HU (1) | HUP0402664A3 (sl) |
| MX (1) | MXPA04005884A (sl) |
| NO (1) | NO20033670L (sl) |
| NZ (1) | NZ533537A (sl) |
| PL (1) | PL207015B1 (sl) |
| PT (1) | PT1321139E (sl) |
| SI (1) | SI1321139T1 (sl) |
| WO (1) | WO2003053429A2 (sl) |
| ZA (1) | ZA200404845B (sl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009502828A (ja) * | 2005-07-28 | 2009-01-29 | シエシー ファルマセウティチィ ソシエタ ペル アチオニ | Ｎｍｄａ受容体遮断薬と麻薬性鎮痛物質とを含む治療用組合せ |
| US8865741B2 (en) | 2011-02-18 | 2014-10-21 | Asana Biosciences, Llc | Aminoindane compounds and use thereof in treating pain |
| US9044482B2 (en) | 2012-08-15 | 2015-06-02 | Asana Biosciences, Llc | Use of aminoindane compounds in treating overactive bladder and interstitial cystitis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2115792C (en) * | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
| IT1283489B1 (it) * | 1996-07-23 | 1998-04-21 | Chiesi Farma Spa | Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico |
| CA2289190A1 (en) * | 1997-05-07 | 1998-11-12 | Algos Pharmaceutical Corporation | Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain |
| WO2000076510A1 (en) * | 1999-06-10 | 2000-12-21 | Bridge Pharma, Inc. | Dermal anesthetic agents |
-
2001
- 2001-12-21 ES ES01130638T patent/ES2270947T3/es not_active Expired - Lifetime
- 2001-12-21 DK DK01130638T patent/DK1321139T3/da active
- 2001-12-21 EP EP01130638A patent/EP1321139B1/en not_active Expired - Lifetime
- 2001-12-21 DE DE60122541T patent/DE60122541T2/de not_active Expired - Lifetime
- 2001-12-21 SI SI200130651T patent/SI1321139T1/sl unknown
- 2001-12-21 PT PT01130638T patent/PT1321139E/pt unknown
- 2001-12-21 AT AT01130638T patent/ATE336990T1/de active
-
2002
- 2002-12-06 HU HU0402664A patent/HUP0402664A3/hu unknown
- 2002-12-06 NZ NZ533537A patent/NZ533537A/en not_active IP Right Cessation
- 2002-12-06 WO PCT/EP2002/013839 patent/WO2003053429A2/en active IP Right Grant
- 2002-12-06 US US10/498,350 patent/US20050222266A1/en not_active Abandoned
- 2002-12-06 PL PL370763A patent/PL207015B1/pl not_active IP Right Cessation
- 2002-12-06 JP JP2003554186A patent/JP4427329B2/ja not_active Expired - Fee Related
- 2002-12-06 EP EP02790474A patent/EP1455771B1/en not_active Expired - Lifetime
- 2002-12-06 CA CA2470990A patent/CA2470990C/en not_active Expired - Fee Related
- 2002-12-06 BR BR0207371-4A patent/BR0207371A/pt not_active IP Right Cessation
- 2002-12-06 MX MXPA04005884A patent/MXPA04005884A/es active IP Right Grant
-
2003
- 2003-08-19 NO NO20033670A patent/NO20033670L/no not_active Application Discontinuation
-
2004
- 2004-06-18 ZA ZA200404845A patent/ZA200404845B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003053429A2 (en) | 2003-07-03 |
| HUP0402664A2 (hu) | 2005-04-28 |
| CA2470990C (en) | 2011-03-29 |
| BR0207371A (pt) | 2004-02-10 |
| NZ533537A (en) | 2006-08-31 |
| MXPA04005884A (es) | 2004-11-01 |
| ATE336990T1 (de) | 2006-09-15 |
| EP1455771B1 (en) | 2006-11-08 |
| EP1321139B1 (en) | 2006-08-23 |
| EP1455771A2 (en) | 2004-09-15 |
| CA2470990A1 (en) | 2003-07-03 |
| DE60122541D1 (de) | 2006-10-05 |
| JP4427329B2 (ja) | 2010-03-03 |
| WO2003053429A3 (en) | 2003-07-31 |
| EP1321139A1 (en) | 2003-06-25 |
| PL370763A1 (en) | 2005-05-30 |
| NO20033670L (no) | 2003-10-21 |
| DE60122541T2 (de) | 2007-09-13 |
| PL207015B1 (pl) | 2010-10-29 |
| HUP0402664A3 (en) | 2012-05-29 |
| ZA200404845B (en) | 2006-07-26 |
| US20050222266A1 (en) | 2005-10-06 |
| PT1321139E (pt) | 2007-01-31 |
| AU2002366727A1 (en) | 2003-07-09 |
| ES2270947T3 (es) | 2007-04-16 |
| JP2005513101A (ja) | 2005-05-12 |
| DK1321139T3 (da) | 2007-01-02 |
| NO20033670D0 (no) | 2003-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE405279T1 (de) | Immobilisierung und stabilisierung von viren | |
| ATE505201T1 (de) | Enzymbehandlung von nahrungsmitteln für zöliakie- sprue | |
| ATE334718T1 (de) | Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln | |
| MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
| DE50203788D1 (de) | Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung | |
| CY1110721T1 (el) | Χρηση glp-2 σε συνδυασμο με αλλο θεραπευτικο παραγοντα σε οστικες παθησεις | |
| BR0110573A (pt) | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de uma composição farmacêutica, utilização do composto e processo para o tratamento profilático ou terapêutico e para a preparação do composto | |
| EE05417B1 (et) | Epotilooni analoogide ja kemoterapeutikumide kombinatsiooni kasutamine teraapias | |
| EP1631316A4 (en) | TARGET BIOCIDES | |
| AU2003272285A8 (en) | Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands | |
| DE60327618D1 (de) | Gegen iap gerichtete antisense-nukleobasen und deren verwendungen | |
| WO2004004757A8 (en) | Treatment for eye disorder | |
| EP1251126A3 (en) | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation | |
| SE0102147D0 (sv) | New methods | |
| SI1321139T1 (sl) | 2-indanilamino-derivati za zdravljenje kronicne, akutne ali vnetne bolecine | |
| EA200500774A1 (ru) | Новая синергетическая комбинация, включающая рофлумиласт и формотерол | |
| MXPA04010816A (es) | Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares. | |
| WO2002067951A3 (de) | Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten | |
| WO2004006843A3 (en) | Combination therapies with l-fmau for the treatment of hepatitis b virus infection | |
| DE60236443D1 (de) | Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie | |
| DE60327249D1 (de) | Anthranilsäureamide und ihre pharmazeutische verwendung | |
| BR0211522A (pt) | Tratamento de dor crÈnica com 3-arilóxi-3-fenilpropanaminas | |
| DE60002172D1 (de) | Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopenten-1-methanol in hbv | |
| DE59405845D1 (de) | Verwendung von 2-Methylamino-2-phenylcyclohexanon zur Behandlung von Infektionen und zur Immunmodulation | |
| ATE472323T1 (de) | Behandlung von statin-nebenwirkungen mit uridinderivaten |